Author: Ravi Shankar

Mechelen, Belgium; September 22, 2026, 22.01 CET; regulated information

Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) (“Lakefront”) announces that between September 14, 2026 and September 18, 2026 it has repurchased 108,679 Lakefront shares via a discretionary mandate to an independent financial intermediary, as follows:

Date of purchase	Market/MTF	Number of shares	Average price paid (€)	Total (€)	Lowest price paid (€)	Highest price paid (€)
14/09/2026	XAMS	20,177	23.47	473,481.55	23.24	23.62
14/09/2026	CEUX	2,697	23.55	63,515.43	23.50	23.58
14/09/2026	AQEU	984	23.56	23,179.30	23.50	23.60
14/09/2026	TQEX	638	23.55	15,027.20	23.52	23.62
15/09/2026	XAMS	20,575	23.31	479,683.49	23.16	23.74
15/09/2026	CEUX	1,673	23.40	39,150.88	23.20	23.72
15/09/2026	AQEU	659	23.23	15,307.58	23.20	23.30
15/09/2026	TQEX	1,676	23.31	39,068.06	23.24	23.44
16/09/2026	XAMS	20,489	24.14	494,606.51	23.70	24.34
16/09/2026	CEUX	2,809	24.12	67,749.43	23.88	24.36
16/09/2026	AQEU	143	24.28	3,472.04	24.28	24.28
16/09/2026	TQEX	1,273	24.25	30,874.83	23.84	24.38
17/09/2026	XAMS	14,964	24.38	364,808.85	24.20	24.86
17/09/2026	CEUX	1,370	24.27	33,247.30	24.20	24.30
17/09/2026	AQEU	400	24.29	9,717.92	24.28	24.34
17/09/2026	TQEX	730	24.28	17,725.71	24.24	24.34
18/09/2026	XAMS	15,116	25.16	380,250.54	25.06	25.40
18/09/2026	CEUX	1,261	25.09	31,643.03	25.06	25.44
18/09/2026	AQEU	861	25.18	21,681.87	25.06	25.44
18/09/2026	TQEX	184	25.22	4,640.55	25.12	25.40
Total		108,679	24.00	2,608,832.08	23.16	25.44

As of market close on 18 September 2026, Lakefront holds 1,527,534 of its own ordinary shares.

About Lakefront Biotherapeutics
Lakefront Biotherapeutics is a biotechnology company dedicated to building a differentiated pipeline of medicines for patients with serious diseases in areas of high unmet need. The Company has established a clinical‑stage portfolio in immunology and inflammation, anchored by gamgertamig, a potential first‑in‑class and best-in-class BCMAxCD3 T‑cell engager for autoimmune diseases. Backed by deep deal‑making expertise, operational flexibility, and a strong capital position, Lakefront identifies, acquires, and advances high‑quality assets with clear potential to deliver meaningful patient impact and long‑term shareholder value. For more information, visit https://www.lakefrontbio.com or follow us on LinkedIn or X.

For further information, contact Lakefront Biotherapeutics:
Investor Relations
Sherri Spear
+1 412 522 6418
sherri.spear@lakefrontbio.com

Richie Livingston
+1 312 636 7072
richie.livingston@lakefrontbio.com

Forward-looking statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, all of which involve certain risks and uncertainties. These statements are often, but are not always, made through the use of words or phrases such as “believe,” “anticipate,” “expect,” “intend,” “plan,” “seek,” “upcoming,” “future,” “estimate,” “may,” “will,” “could,” “would,” “potential,” “forward,” “goal,” “next,” “continue,” “should,” “encouraging,” “aim,” “progress,” “remain,” “explore,” and “further,” as well as similar expressions. These statements include, but are not limited to, statements regarding Lakefront’s plans to repurchase its ordinary shares. Lakefront cautions the reader that forward-looking statements are based on our management’s current expectations and beliefs and are not guarantees of future performance. Forward-looking statements may involve known and unknown risks, uncertainties and other factors which might cause actual events, financial condition and liquidity, performance, or achievements, or the industry in which we operate, to be materially different from any historic or future results, financial conditions, performance or achievements expressed or implied by such forward-looking statements. In addition, even if our results, performance, financial condition and liquidity, and the development of the industry in which Lakefront operates are consistent with such forward-looking statements, they may not be predictive of results or developments in future periods. Such risks include, but are not limited to, those risks and uncertainties that can be found in our filings and reports with the Securities and Exchange Commission (“SEC”), including in our most recent annual report on Form 20-F filed with the SEC and our subsequent filings and reports filed with the SEC. Given these risks and uncertainties, the reader is advised not to place any undue reliance on such forward-looking statements. In addition, even if the result of our operations, financial condition and liquidity, or the industry in which we operate, are consistent with such forward-looking statements, they may not be predictive of results, performance or achievements in future periods. These forward-looking statements speak only as of the date of publication of this release. We expressly disclaim any obligation to update any such forward-looking statements in this release to reflect any change in our expectations or any change in events, conditions or circumstances, unless specifically required by law or regulation.

Attachment

• 20260918 LakefrontEN RNS Announcement

WAUWATOSA, Wis., Sept. 22, 2026 (GLOBE NEWSWIRE) — The Board of Directors of Waterstone Financial, Inc. (NASDAQ: WSBF) declared a regular quarterly cash dividend of $0.17 per common share. The dividend is payable on November 2, 2026, to shareholders of record at the close of business on October 8, 2026.

About Waterstone Financial, Inc:
Waterstone Financial, Inc. is the savings and loan holding company for WaterStone Bank, a community-focused financial institution established in 1921. WaterStone Bank offers a comprehensive suite of personal and business banking products and operates 14 branch locations across southeastern Wisconsin. WaterStone Bank is also the parent company of WaterStone Mortgage Corporation, a national lender licensed in 48 states.

With a long-standing commitment to innovation, integrity, and community service, Waterstone Financial, Inc. supports the financial and homeownership goals of customers nationwide.

For more information about WaterStone Bank, visit wsbonline.com.

Contact:
Mark R. Gerke
Chief Financial Officer
414.459.4012
markgerke@wsbonline.com

NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) — IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ) T cell therapies and T cell engagers for cancer and autoimmune diseases, today announced that William Ho, Chief Executive Officer and Co-Founder, will participate in the Sidoti Small-Cap Virtual Conference, held September 23-24, 2026.

Mr. Ho will participate in one-on-one meetings with investors throughout the conference and deliver a company presentation on Thursday, September 24. The presentation will provide an overview of IN8bio’s differentiated γδ T cell platform and pipeline, including its lead T cell engager program, INB-619, and clinical-stage programs in oncology.

Sidoti Small-Cap Virtual Conference
Date: Thursday, September 24, 2026
Time: 1:00 p.m. ET
Presenter: William Ho, Chief Executive Officer and Co-Founder
Webcast: https://sidoti.zoom.us/webinar/register/WN_bRXGkMX_Tqy0GgJJ6QJ4qg

A live webcast of the presentation will be available through the Investors section of IN8bio’s website. A replay will be available following the event.

About IN8bio
IN8bio is a clinical-stage biopharmaceutical company developing γδ T cell and γδ T cell engager (TCE) product candidates to address unmet medical needs. γδ T cells are a specialized population of T cells that possess unique properties, including the ability to differentiate between healthy and diseased tissue. The Company’s pipeline is anchored by INB-600, a novel γδ T cell engager platform with potential applications across oncology and autoimmune indications. IN8bio is also advancing INB-100, an allogeneic γδ T cell candidate for adult patients with high-risk leukemias undergoing haploidentical stem cell transplantation, and INB-200/400, an autologous genetically modified γδ T cell candidate for newly diagnosed glioblastoma (GBM). For more information about IN8bio, visit www.IN8bio.com.

Investors and Corporate Contact:
IN8bio, Inc.
Patrick McCall
646.933.5603
pfmccall@IN8bio.com

Media Contact
Kimberly Ha
KKH Advisors
917.291.5744
kimberly.ha@kkhadvisors.com

MACAU, Sept. 22, 2026 (GLOBE NEWSWIRE) — Zenta Group Company Limited (“Zenta Group” or the “Company”) (Nasdaq: ZTG), a Macau-based professional services provider engaged in industrial park consultation, business investment consultation, and the sale of fintech and artificial-intelligence products and services, today announced that it has filed a shelf registration statement on Form F-3 (the “Registration Statement”) with the U.S. Securities and Exchange Commission (the “SEC”).

The Registration Statement, once declared effective by the SEC, would allow the Company to offer and sell, from time to time in one or more offerings, up to an aggregate of US$50,000,000 of its Class A ordinary shares, par value US$0.001 per share, debt securities, warrants, rights, and units, or any combination thereof, together or separately.

The Registration Statement was filed on September 22, 2026 and has not yet become effective. The specific terms of any securities offered, and the intended use of proceeds for that offering, will be described in a prospectus supplement and any related free writing prospectus to be filed with the SEC at the time of the offering. Except as may be described in an applicable prospectus supplement, the Company currently intends to use the net proceeds from any sale of securities under the Registration Statement for general corporate purposes.

The Company is filing the Registration Statement to provide financial flexibility. The filing of the Registration Statement does not mean that any securities will be offered or sold, and the Company has no present commitment or obligation to offer or sell any securities under it.

The Registration Statement, including the preliminary prospectus contained therein, is available on the SEC’s website at www.sec.gov. Before investing in any securities that may be offered, investors should read the prospectus in the Registration Statement, any applicable prospectus supplement, and the other documents the Company has filed with the SEC that are incorporated by reference therein for more complete information about the Company and any such offering.

No Offer or Solicitation

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. A registration statement relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. Any offering of securities under the Registration Statement will be made only by means of a prospectus and a related prospectus supplement forming part of the effective registration statement.

About Zenta Group Company Limited

Founded in 2019, Zenta Group Company Limited is a diversified consulting, fintech, and artificial-intelligence solutions provider based in Macau. Through its operating subsidiaries, the Company provides industrial park consultation, business investment consultation, and fintech products and services, and, following its acquisition of ZentoAI Intelligent Technology Company Limited in September 2026, artificial-intelligence and data platform services. Zenta Group supports clients — primarily from China’s Greater Bay Area — in navigating commercial project approvals, acquiring equity stakes in targeted opportunities, and accessing fintech and AI solutions.

For more information, please visit the Company’s investor relations website: https://ir.zenta.mo

Forward-Looking Statements

Certain statements in this announcement are forward-looking statements, including, but not limited to, statements regarding the Registration Statement, whether and when the Registration Statement may be declared effective by the SEC, whether the Company will offer or sell any securities thereunder, the timing, size, terms, and completion of any such offering, and the anticipated use of proceeds of any such offering. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy, and financial needs, including market conditions and the satisfaction of customary closing conditions for any offering. Investors can identify these forward-looking statements by words or phrases such as “approximates,” “believes,” “hopes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “plans,” “will,” “would,” “should,” “could,” “may,” or other similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results, and encourages investors to review the risk factors and other information in the Registration Statement and in the Company’s other filings with the SEC, including its Annual Report on Form 20-F for the fiscal year ended September 30, 2025.

CONTACT: For investor and media inquiries, please contact:

Zenta Group Company Limited, Investor Relations, Avenida do Infante D. Henrique, No. 47-53A, Macau Square, 13th Floor, Unit M, Macau 999078 Tel: +853 2840 0625 Email: ir@zenta.mo

Sought-after Ingram Dunes coastal community is down to its last remaining move-in ready home

MYRTLE BEACH, S.C., Sept. 22, 2026 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced the final opportunity to purchase a new home in its Toll Brothers at Ingram Dunes community in Myrtle Beach, South Carolina. In sought-after Myrtle Beach, only one home remains at Toll Brothers’ Ingram Dunes community located at 512 9^th Avenue S in Myrtle Beach.

Toll Brothers at Ingram Dunes in North Myrtle Beach has just one home remaining with 4 bedrooms and 3.5 baths in 2,885 square feet priced at $599,000.

“This home represents the last opportunity for home shoppers to own a new construction home in this popular Myrtle Beach community,” said Jason Simpson, Group President of Toll Brothers in South Carolina. “We encourage home shoppers to explore this distinctive home design in Myrtle Beach, offering gracious living and tremendous value in a premier coastal setting just minutes from the beach.”

Living along South Carolina’s Grand Strand offers an exceptional coastal lifestyle with easy access to beautiful beaches, championship golf courses, and endless outdoor recreation. This Toll Brothers community is ideally located near boating, fishing, waterfront dining, shopping, entertainment, and local attractions, while still providing a relaxed, coastal atmosphere. Ingram Dunes also features desirable amenities such as community pools, making it easy to enjoy an active, resort-style lifestyle year-round.

For more information on Toll Brothers communities in South Carolina, contact Toll Brothers at 866-232-1717 or visit TollBrothers.com/SC.

About Toll Brothers

Toll Brothers, Inc., a Fortune 500 Company, is the nation’s leading builder of luxury homes. The Company was founded in 1967 and became a public company in 1986 with common stock listed on the New York Stock Exchange under the symbol “TOL.” Toll Brothers builds new homes and communities in over 60 markets across the United States, serving first-time, move-up, active-adult, and second-home buyers. The Company also operates its own architectural, engineering, mortgage, title, land development, smart home technology, landscape, and building components manufacturing businesses.

Toll Brothers was named the #1 Most Admired Home Builder in Fortune magazine’s 2026 list of the World’s Most Admired Companies®, the ninth year the Company has achieved this honor. Toll Brothers has also been named Builder of the Year by Builder magazine and is the first two-time recipient of Builder of the Year from Professional Builder magazine. For more information visit TollBrothers.com.

From Fortune, ©2026 Fortune Media IP Limited. All rights reserved. Used under license.

Contact: Andrea Meck | Toll Brothers, Senior Director, Public Relations & Social Media | 215-938-8169 | ameck@tollbrothers.com

Photos accompanying this announcement are available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/09e8d264-ca87-4a35-bb1e-6029e580b9c0
https://www.globenewswire.com/NewsRoom/AttachmentNg/34528a92-1030-42b7-b1fa-397b863fefc7
https://www.globenewswire.com/NewsRoom/AttachmentNg/5c24e149-72b7-4939-b222-18013f805d1e

Sent by Toll Brothers via Regional Globe Newswire (TOLL-REG)

River Point Collection offers low-maintenance living with resort-style amenities

CHARLOTTE, N.C., Sept. 22, 2026 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced its newest collection of luxury townhomes, Toll Brothers at the River District – River Point Collection, is coming soon to Charlotte, North Carolina. Located near the Catawba River within the highly anticipated master-planned community of The River District, this new collection will feature low-maintenance luxury townhomes designed for modern living. Site work is underway and the collection is anticipated to open for sale in early 2027.

The River Point Collection at Toll Brothers at The River District will offer stylish two-story townhomes with 3 bedrooms, 2.5 bathrooms, and up to 2,000 square feet of living space. Homes will also feature versatile loft spaces, 2-car garages, and curated Designer Appointed Collections from the Toll Brothers Design Studio that allow home shoppers to create a unique and cohesive interior design that reflects their style. The community is expected to be priced from the upper $400,000s.

Toll Brothers customers will experience one-stop shopping at the Toll Brothers Design Studio. The state-of-the-art Design Studio allows home shoppers to choose from a wide array of selections to personalize their dream home with the assistance of Toll Brothers professional Design Consultants.

Residents of River Point Collection will enjoy access to the resort-style amenities of The River District, including multiple pools, a clubhouse, a fitness center, walking and biking trails, a dog park, a community garden, and an outdoor fireplace. The community’s onsite farm and river access offer opportunities for outdoor recreation and connecting with nature. Lawn maintenance and trash removal are included, providing a low-maintenance lifestyle for residents.

“We are thrilled to introduce our River Point Collection of townhomes to home shoppers in The River District in Charlotte,” said Ryan Switzer, Division President of Toll Brothers in Charlotte. “This new collection offers the perfect blend of low-maintenance living, luxury design, and access to outstanding amenities, all in a convenient location close to everything the vibrant city of Charlotte has to offer.”

The River District is ideally situated just minutes from Uptown Charlotte, offering a lively atmosphere with diverse shopping, dining, and entertainment options. The community is also conveniently located near Charlotte Douglas International Airport, making it easy for residents to travel.

For more information and to join the Toll Brothers interest list for Toll Brothers at the River District – River Point Collection, call (866) 232-1719 or visit TollBrothers.com/NC.

About Toll Brothers

Toll Brothers, Inc., a Fortune 500 Company, is the nation’s leading builder of luxury homes. The Company was founded in 1967 and became a public company in 1986 with common stock listed on the New York Stock Exchange under the symbol “TOL.” Toll Brothers builds new homes and communities in over 60 markets across the United States, serving first-time, move-up, active-adult, and second-home buyers. The Company also operates its own architectural, engineering, mortgage, title, land development, smart home technology, landscape, and building components manufacturing businesses.

Toll Brothers was named the #1 Most Admired Home Builder in Fortune magazine’s 2026 list of the World’s Most Admired Companies®, the ninth year the Company has achieved this honor. Toll Brothers has also been named Builder of the Year by Builder magazine and is the first two-time recipient of Builder of the Year from Professional Builder magazine. For more information visit TollBrothers.com.

From Fortune, ©2026 Fortune Media IP Limited. All rights reserved. Used under license.

Contact: Andrea Meck | Toll Brothers, Senior Director, Public Relations & Social Media | 215-938-8169 | ameck@tollbrothers.com

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/37c21568-c6fb-4278-aa5b-5b671d03e20f

https://www.globenewswire.com/NewsRoom/AttachmentNg/4c178ca8-6351-4249-b684-88c4b12ce7c9

https://www.globenewswire.com/NewsRoom/AttachmentNg/2388f645-9e45-424a-bc8a-122d54e34862 

Sent by Toll Brothers via Regional Globe Newswire (TOLL-REG)

MONTREAL, Sept. 22, 2026 (GLOBE NEWSWIRE) — CN (TSX: CNR) (NYSE: CNI) and Total Grain Marketing (TGM) announced that on September 16^th, 2026, CN shipped the first unit train from TGM’s recently expanded grain elevator at Lis, Illinois. The project includes a new 115-car loop track that replaces the existing 25-car footprint, along with expanded receiving, storage, and shipping capacity.

The expansion at Lis includes the construction of 3.1 million bushels of grain storage capacity along with three truck dump pits that allow the facility to receive up to 85,000 bushels of grain per hour. New shipping capacity will allow unit trains to be loaded in as little as eight hours.

“Lis represents the biggest project in the history of TGM. We appreciate the partnership and engagement with CN every step of the way through this project.”

 – Ken Meinhart, Grain Division Manager, Total Grain Marketing

“The operational efficiencies that this project will generate for TGM, its customers, and CN will make a real difference to the end-to-end grain supply chain in CN’s Southern Region.”

 – Nicole James, Vice-President Transportation Southern Region, CN

“We are proud to be working so closely with TGM in making this project a reality. We look forward to working with our long-term partner to create value for both TGM and its customers.”

 – Sandra Ellis, Vice-President, Bulk, Industrial and Business Development, CN

CN continues to work closely with customers and supply chain partners to bring new projects online, supporting long-term economic growth while strengthening the resilience and competitiveness of North American supply chains.

About CN
CN powers the economy by safely transporting more than 300 million tons of natural resources, manufactured products, and finished goods throughout North America every year for its customers. With its nearly 20,000-mile rail network and related transportation services, CN connects Canada’s Eastern and Western coasts with the U.S. Midwest and the U.S. Gulf Coast, contributing to sustainable trade and the prosperity of the communities in which it operates since 1919.

About TGM:
Total Grain Marketing (TGM) is a full-service grain company dedicated to providing comprehensive grain marketing solutions to meet the needs of both producers and consumers. Established in 2006 as a joint venture between South Central FS, GROWMARK, Inc., and Wabash Valley Service Company, TGM operates 25 elevators across Illinois and Indiana.

Contacts: 

Media	Investment Community
Ashley Michnowski	Jamie Lockwood
Senior Manager	Vice-President
Media Relations	Investor Relations and Special Projects
(438) 596-4329	(514) 399-0052
media@cn.ca	investor.relations@cn.ca

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/9196ccb0-5d2e-426e-b9cd-84899a0b6b2c
https://www.globenewswire.com/NewsRoom/AttachmentNg/5a3fa852-fb5b-45d0-9f65-58bed8d152a3
https://www.globenewswire.com/NewsRoom/AttachmentNg/b61c1c7c-9444-4697-83e9-5b53abeeb5ee

Planned Board refresh adds defense, autonomy and public company leadership experience as Hoshi Printer and Jim Auker conclude their service at the 2026 Annual Meeting in November

IRVINE, Calif., Sept. 22, 2026 (GLOBE NEWSWIRE) — Lantronix Inc. (Nasdaq: LTRX), a global provider of Edge AI and Industrial IoT solutions that power NDAA-compliant unmanned systems, critical infrastructure and resilient enterprise networks, today announced that its Board of Directors has nominated Jason Lamb, a former U.S. Navy SEAL officer and defense technology executive, for election as an independent director at the company’s 2026 Annual Meeting of Stockholders on Nov. 3, 2026.

As part of a planned Board refresh, Chair of the Board Hoshi Printer and Director Jim Auker will not stand for re-election and will conclude their Board service at the Annual Meeting of Stockholders in early November. Printer joined the Board in 2010 and has served as Chair of the Audit Committee since 2010 and as Chair of the Board since 2024. Auker joined the Board in 2025 and has served on the Audit Committee.

“It has been a privilege to serve Lantronix for 16 years and to help guide the company through a period of significant transformation,” said Printer. “With a strong balance sheet, a clear strategy and growing opportunities across its key markets, I believe this is the right time for the next phase of Board leadership. I am confident in the Board and management team as they continue to execute the company’s strategy.”

“On behalf of the Board and our employees, I want to thank Hoshi and Jim for their service,” said Saleel Awsare, President and CEO of Lantronix. “Hoshi’s financial discipline and steady leadership helped position Lantronix with the balance sheet and focused strategy we have today, and Jim brought valuable M&A and corporate advisory perspective to our Audit Committee. We are grateful to them both.”

“Jason’s experience at the intersection of national security, autonomous systems and technology commercialization will be a valuable addition to our Board as we continue to scale our unmanned systems business. His background as a Navy SEAL officer, defense technology executive and public company CEO will bring a highly relevant perspective as we deepen our relationships with defense customers and accelerate the commercialization of our Edge AI solutions,” Awsare concluded.

Lamb is chief executive officer of The LGL Group Inc. (NYSE American: LGL). He brings more than 20 years of leadership experience across special operations, intelligence, technology development and private equity investing. He serves on the Board of Directors of the Association for Uncrewed Vehicle Systems International (AUVSI), the world’s largest organization devoted to advancing the uncrewed systems and robotics industry, and is a director of Alpha G Investment Management Inc. (formerly Teton Advisors Inc.). He previously served as a special advisor to LGL Systems Acquisition Corporation. Lamb also served as chief strategy officer of BlackSea Technologies, a private equity-backed platform focused on maritime defense technologies, following BlackSea’s acquisition of Hard Yards, the company he founded. Earlier in his career, he served as an officer in the U.S. Navy SEAL teams.

Lamb holds an M.B.A. from the University of Virginia Darden School of Business, an M.S. in Management of Information Technology from the University of Virginia, an M.A. in National Security and Strategic Studies from the U.S. Naval War College and a B.S. in Political Science from the U.S. Naval Academy.

“Lantronix is well positioned at the intersection of Edge AI, autonomy and defense, with NDAA-compliant platforms already supporting mission-critical unmanned systems,” said Lamb. “The company has the technology, customer relationships and growing program base to build a much larger business in this market. I look forward to working with the Board and management team to help accelerate that opportunity.”

Lantronix’s unmanned systems business generated $12.6 million in revenue in fiscal 2026 and is expected to represent 15% to 20% of total revenue in fiscal 2027. The company has more than 30 active engagements across defense, commercial and public safety applications, spanning drones, autonomy, imaging and other Edge AI applications. Publicly disclosed customers and partners include Teal Drones, a Red Cat Holdings Inc. (Nasdaq: RCAT) company; Sightline Intelligence; Swarmer Inc. (Nasdaq: SWMR); DoD Solution, a Ukrainian drone company; and AVT Australia, a CACI International Inc. (NYSE: CACI) company.

About Lantronix

Lantronix Inc. (Nasdaq: LTRX) is a global leader in Edge AI and Industrial IoT solutions that power NDAA-compliant unmanned systems, critical infrastructure and resilient enterprise networks. It delivers intelligent computing, secure connectivity and remote management for mission-critical applications, enabling customers to optimize operations, enhance security and accelerate digital transformation. Its comprehensive portfolio of hardware, software and services powers applications ranging from mission-critical autonomous platforms and edge analytics for critical infrastructure to intelligent surveillance and secure network management. By bringing intelligence to the network edge, Lantronix helps organizations achieve efficiency, security and a competitive edge in today’s AI-driven world. For more information, visit the Lantronix website.

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking statements within the meaning of federal securities laws, including, without limitation, statements concerning the composition of our Board of Directors following the 2026 Annual Meeting of Stockholders, the expected contribution of unmanned systems to our revenue in fiscal 2027, the continuation of existing customer programs, our expectations for revenue growth and Lantronix’s positioning to capitalize on opportunities in the aerospace, defense and unmanned systems markets. These forward-looking statements are based on our current expectations and are subject to substantial risks and uncertainties that could cause our actual results, future business, financial condition or performance to differ materially from our historical results or those expressed or implied in any forward-looking statement contained in this news release. The potential risks and uncertainties include, but are not limited to, such factors as the outcome of the stockholder vote at the 2026 Annual Meeting; the effects of negative or worsening regional and worldwide economic conditions or market instability on our business, including effects on purchasing decisions by our customers; our ability to mitigate any disruption in our and our suppliers’ and vendors’ supply chains due to changes in U.S. or foreign government trade policies, including recently increased or future tariffs, a pandemic or other outbreaks, wars and recent conflicts in Europe, Asia and the Middle East or other factors; changes in U.S. and foreign government defense spending priorities and procurement; future responses to and effects of public health crises; cybersecurity risks; changes in applicable U.S. and foreign government laws and regulations; our ability to successfully implement our acquisitions strategy or integrate acquired companies; difficulties and costs of protecting patents and other proprietary rights; and any additional factors included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2026, filed with the Securities and Exchange Commission (the “SEC”) on Aug. 27, 2026, including in the section entitled “Risk Factors” in Item 1A of Part I of that report, as well as in our other public filings with the SEC. Additional risk factors may be identified from time to time in our future filings. In addition, actual results may differ as a result of additional risks and uncertainties about which we are currently unaware or which we do not currently view as material to our business. For these reasons, investors are cautioned not to place undue reliance on any forward-looking statements. The forward-looking statements we make speak only as of the date on which they are made. We expressly disclaim any intent or obligation to update any forward-looking statements after the date hereof to conform such statements to actual results or to changes in our opinions or expectations, except as required by applicable law or the rules of the Nasdaq Stock Market LLC. If we do update or correct any forward-looking statements, investors should not conclude that we will make additional updates or corrections.

©2026 Lantronix Inc. All rights reserved. Lantronix is a registered trademark. Other trademarks and trade names are those of their respective owners.

Investor Contact:

Matt Glover and Greg Robles
Gateway Group Inc.
LTRX@gateway-grp.com

Media Contact:

Diana Puckett
PRforLantronix@Bospar.com

DENVER, Sept. 22, 2026 (GLOBE NEWSWIRE) — (247marketnews.com)– NeOnc Technologies Holdings (NASDAQ: NTHI) is becoming a prominent player, as brain cancer research is entering an increasingly sophisticated era.

However, one of the field’s biggest problems remains stubbornly simple: getting effective therapy to the tumor while protecting the brain from additional damage. A July 2026 review in Science Translational Medicine described glioblastoma as remaining one of the most aggressive adult brain cancers, with survival still largely unchanged despite advances in molecular diagnostics and supportive care. At the same time, researchers are pursuing an expanding menu of approaches; targeted therapies, immunotherapy, tumor-treating fields, focused delivery technologies and molecularly selected treatments.

One of the most important developments has been the increasing use of molecular biomarkers to divide brain tumors into more precisely defined diseases. The FDA’s recent brain-tumor approvals illustrate the trend: therapies are increasingly being developed around specific molecular alterations rather than treating every tumor as biologically identical. Vorasidenib, for example, targets susceptible IDH1/IDH2-mutant tumors, while other recent approvals have focused on specific alterations in pediatric brain cancers.

That is where NeOnc enters the story with NEO100. Rather than attempting to solve the blood-brain barrier problem by forcing a conventional systemic drug through it, NEO100 uses an intranasal delivery approach designed to reach the central nervous system through the nasal/olfactory pathway. The company’s Phase 2a study specifically enrolled patients with recurrent or progressive Grade III and Grade IV glioma carrying an IDH1 mutation; a biomarker-defined population where the company is attempting to establish a targeted development path.

The August 2026 Phase 2a readout gives investors and researchers a reason to pay attention, while also demanding caution. NeOnc reported six-month progression-free survival of 48.9% versus a prespecified 20% benchmark, with a reported p-value of 0.0047. Median overall survival was 26.09 months, and five of 24 patients remained on treatment at the data cutoff. The company also reported no major toxicities across the cohort, with adverse events predominantly low-grade.

The appropriate takeaway being that NEO100 generated a clinical signal worthy of further investigation.

The broader competitive landscape underscores both the opportunity and the challenge. The National Cancer Institute currently lists numerous active glioblastoma trials involving combinations of chemotherapy, radiation, immunotherapy, targeted agents, tumor-treating fields and other experimental approaches. Meanwhile, Novocure’s Phase 3 TRIDENT study did not meet its primary endpoint for overall survival when tumor-treating fields were initiated earlier, illustrating how difficult it remains to translate promising therapeutic concepts into statistically conclusive clinical benefits.

For NeOnc, the next major question is therefore whether the NEO100 signal can be reproduced in a larger, better-controlled study. The company says it plans to seek a Type B meeting with the FDA to discuss a potential registrational pathway for recurrent IDH1-mutant high-grade glioma. That regulatory discussion could help clarify what evidence would be required for the program’s next stage.

The bigger significance of NEO100 may ultimately extend beyond a single drug. If intranasal delivery can demonstrate that therapeutically meaningful exposure to the brain can be achieved while maintaining tolerability, it could strengthen interest in the nose-to-brain delivery concept itself.

About 24/7 Market News

In today’s fast-moving markets, visibility is everything and 24/7 Market News (24/7) provides a powerful suite of investor relations and public relations solutions designed to elevate your company’s profile quickly and effectively. Whether you’re an established name seeking broader awareness, or a micro-cap looking to break out of obscurity, 24/7 delivers targeted, high-impact coverage through timely news distribution, analyst report placements, featured editorials, and multi-channel amplification across financial platforms, social media, and investor communities. Our services help cut through the noise, attract institutional interest, drive exposure, and build long-term shareholder credibility, all while maintaining full SEC compliance and transparency. For Analyst Report coverage, custom IR campaigns, press release syndication, or other tailored investor and public relations solutions, contact sales@247mnn.com to discuss how 24/7 can help accelerate your company’s visibility and valuation trajectory.

This is a paid editorial communication intended for informational purposes only. 24/7 is compensated by NTHI to provide ongoing news coverage of expected upcoming catalysts and events as well as market outreach services. For further disclosure information, please click here. This should not be construed as financial or investment advice. Trading involves substantial risk; consult your financial advisor.

Important Editorial Note: 247 highlights companies approaching significant catalysts and inflection points. This report reflects information available at the time of publication.  Since developments can occur rapidly, readers should independently verify current information and review all company filings and disclosures.

CONTACT:
24/7 Market News
Editor@247mnn.com

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company’s ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Actual results could differ materially from those described in these forward-looking statements due to a number of factors, including without limitation, the Company’s ability to continue as a going concern, general economic conditions, and other risk factors detailed in the Company’s filings with the SEC. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update such forward-looking statements except in accordance with applicable law.

Drawing on Zapata’s pioneering quantum software expertise, the platform helps enterprises build a clear roadmap to commercial impact

BOSTON, Sept. 22, 2026 (GLOBE NEWSWIRE) — Zapata Quantum, Inc. (OTCQB: ZPTA) (“Zapata,” “Zapata Quantum” or the “Company”), a leader in quantum computing algorithm and application development, today announced early access to Quantum Pilot, a hardware-agnostic, cloud-based software platform designed to close a growing gap between rapidly advancing quantum hardware capabilities and enterprises’ ability to determine where and how quantum computing can create business value.

Quantum Pilot builds a dynamic roadmap for enterprises that want to deploy quantum technology but are uncertain which applications are relevant to their business and sector, when those solutions will be practical, and what they could be worth. It gives organizations a systematic way to discover potential applications, weigh their technical and commercial potential, and focus resources on the opportunities with the strongest case for investment. Enterprises can then identify and develop applications without betting on a single quantum modality or provider, and reassess application readiness or change their approach as hardware capabilities and algorithms evolve.

“The critical on-ramp to quantum application development is the efficient and rigorous mapping of use cases to quantum computational solutions,” said Sumit Kapur, CEO of Zapata Quantum. “We built Quantum Pilot to make that on-ramp more accessible to enterprise leaders and ensure that quantum activity becomes a capability that compounds—with each experiment and development effort informing and accelerating the next.”

Delivering Quantum Application Intelligence™

Drawing on Zapata’s experience developing quantum algorithms and applications across industries and hardware architectures, Quantum Pilot combines a proprietary knowledge framework with advanced computational tools, including capabilities developed through its collaboration with NVIDIA to apply agentic AI to quantum resource estimation. The platform also builds on Zapata’s collaboration with the University of Maryland on formal methods for quantum software verification.

Together, these capabilities enable Quantum Pilot to deliver Quantum Application Intelligence (QAI)—helping enterprises identify, evaluate and develop quantum applications with scientific rigor and a clear focus on business value. The platform also continuously tracks and updates the global quantum ecosystem’s research, hardware roadmaps and software developments so that application roadmaps are current as the field advances and users are making application decisions based on the latest data.

“Most conversations about quantum readiness focus on the hardware roadmap. That is not where the real risk sits. It sits one layer up, in the applications and software that decide whether the hardware ever produces business value,” said Mark Hill, Chief Digital Information Officer at CSL Behring, a multibillion-dollar global biotech leader, and Advisor to the Company. “Quantum Pilot matters because it forces the harder question enterprises keep avoiding: which applications are worth building now, not just which processor is fastest.”

Quantum Pilot is powered by three complementary systems:

• Quantum Graph, a proprietary knowledge layer that connects quantum applications, algorithms, research, and hardware roadmaps, providing structured context for the platform and its AI agents as the field advances.
• Quantum Engine, a suite of computational tools and agents that supports algorithm selection, resource estimation, experiment design and hardware benchmarking, helping enterprises assess technical feasibility and guide application development.
• Quantum Assurance, a framework that combines formal verification methods with expert review to assess technical results and guide the development process, with Zapata’s scientists helping enterprises interpret evidence and determine next steps.

“Among the things that make Quantum Pilot’s approach to application development distinct is its use of formal verification, rather than after-the-fact validation alone,” said Runzhou Tao, Assistant Professor, University of Maryland, and Fellow, Joint Center for Quantum Information and Computer Science (QuICS). “That’s the same principle we apply in our research with Zapata on verified quantum software, and it addresses a discipline quantum computing has largely developed without.”

Early Access

Quantum Pilot is initially available through an early access program for select enterprise and government customers. Organizations interested in participating can request a demo and learn more at zapataquantum.com/quantumpilot.

About Zapata Quantum
Zapata Quantum is a leading hardware-agnostic, pure-play quantum software company focused on accelerating quantum application development. With a portfolio of more than 60 granted and pending patents developed over seven years, Zapata supports applications across cryptography, pharmaceuticals, finance, materials discovery, defense, and more. Spun out of Harvard’s quantum lab in 2017, the Company is the only organization to have participated across all technical areas of DARPA’s Quantum Benchmarking program and has worked with Fortune 500 enterprises and government agencies to translate quantum advances into real-world impact. The Company’s study demonstrating the potential of quantum-enabled drug discovery was recognized as one of Nature Biotechnology’s Top 10 Papers of 2025.

Media Contact
Taylor White
taylor@hkamarcom.com

Investor Relations Contact
Richard Land
investors@zapataquantum.com

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, Zapata Quantum’s building the tools to help close the quantum applications gap, the potential features and benefits of our new product offering, accelerating quantum application and development, plans and ability to discover and develop quantum computer opportunities and create business value, and our ability to deliver our proprietary capabilities to deliver quantum application intelligence. Forward-looking statements may be prefaced by words such as “anticipate,” “expect,” “plan,” “could,” “may,” “will,” “should,” “would,” “intend,” “seem,” “potential,” “appear,” “continue,” “future,” “believe,” “estimate,” “forecast,” “project,” and similar words and expressions as they relate to us, are intended to identify forward-looking statements. Forward-looking statements are neither historical facts nor assurances of future performance, and are based on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict, many of which are outside of our control. We caution you, therefore, against relying on any of these forward-looking statements. Our actual results may differ materially from those contemplated by the forward-looking statements for a variety of reasons, including, without limitation, our ability to close the quantum applications gap between quantum hardware capabilities and identify and capitalize on the recognition and competitive advantages associated with quantum computing technologies, our ability to identify and develop potential applications and advances in quantum applications, our ability to secure and maintain contracts with customers and collaborators, the state of the U.S. economy including issues caused by affordability, the risk of future inflation and uncertainty surrounding interest rates and the possibility of a recession, uncertainty surrounding and impacts arising from tariffs and developments relating thereto, our ability to attract and retain key personnel, our ability to obtain, maintain and protect intellectual property rights, the risk that software and technology infrastructure on which we depend fails to perform as designed or intended, the possibility that competitors may develop or access technology with similar or superior capabilities to our technology offerings, the possibility of adverse regulatory developments that could adversely impact us or our collaborators or the technologies on which we depend, and the risk factors contained in our Annual Report on Form 10-K for the year ended December 31, 2025 filed with the U.S. Securities and Exchange Commission (the “SEC”) on March 31, 2026, and our Prospectus filed with the SEC on August 11, 2026. Any forward-looking statement made by us in this press release speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.